Has Violiza Acosta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $104,821 in general payments to Violiza Acosta, MD across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Violiza Acosta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Violiza Acosta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Violiza Acosta, MD

Vascular Neurology · Memphis, TNNPI 1114158698

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $65,758 of the $104,821 with a category attached, or 62.7%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 30.8% of the total. Reporting peaked in 2024 at $30,582 and has fallen 99.2% since, to $232 in 2025.

$104,821in general payments, 2019–2025

Across 164 payments — averaging $639.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$32K
Microvention, Inc.$27K
Medtronic$26K
Siemens Medical Solutions USA, Inc.$11K
Viz.ai, Inc.$5K
Penumbra, Inc.$2K
plus $1K from 8 others

$443,812in research payments, 2019–2025

Across 71 payments — averaging $6250.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$412K
Microvention, Inc.$30K
Medtronic$2K

What the payments were for

Consulting fees$65,75863%
Speaking & faculty fees$22,72922%
Travel & lodging$9,2359%
Food & beverage$7,0957%
Gifts$40%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	32	$32,323
Microvention, Inc.	22	$27,184
Medtronic(2 entities)	72	$25,874
Siemens Medical Solutions USA, Inc.	14	$11,344
Viz.ai, Inc.	1	$5,400
Penumbra, Inc.	7	$1,690
Silk Road Medical, Inc.	3	$395
Imperative Care, Inc	4	$233
Balt USA, LLC	2	$174
Johnson & Johnson	2	$78
Stryker	1	$44
Boston Scientific	2	$33
Scientia Vascular	1	$32
Sanofi-aventis U.S. LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TRUFILL$31,457
WEB Aneurysm Embolization System$25,706
Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$25,113
Embotrap$22,737
CEREPAK UNIFORM$22,613
HYDROSOFT ADVANCED$19,919
Pipeline$14,340
PULSERIDER$6,343
Viz.AI LVO$5,400
SOLITAIRE X$3,301
Penumbra System$1,461
ONYX 18$1,134
ENROUTE Transcarotid Neuroprotection System$334
ENROUTE Transcarotid Stent System$334
ENHANCE Transcarotid Peripheral Access Kit$334
ENROUTE 0.014 Guidewire$334
STENT$269
ZOOM 88-T LARGE DISTAL PLATFORM$158
Artis Q$140
Benchmark$139

How this compares

Too few vascular neurology providers in Tennesseeto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$204,175

Medicare patients

247

Services billed

5,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	36	$27,853
BrilintaTicagrelor	46	$21,801
Aspirin-Dipyridamole ErAspirin/Dipyridamole	24	$4,549
Lacosamide	13	$2,514
Levetiracetam	27	$1,430
ClopidogrelClopidogrel Bisulfate	33	$572
Atorvastatin Calcium	30	$327

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Memphis

Kaushik ParshaMemphis$786
Beth Anne CavanaughMemphis$433
Nirav ShahMemphis$356
Savdeep SinghMemphis$202
Deborah KerriganNashville$7K
Himanshu PatelNashville$6K
David ParrellaNashville$5K
David CurfmanNashville$3K
Charles CapeGermantown$2K
Cory RiceChattanooga$732

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →